These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

426 related items for PubMed ID: 22895515

  • 21. Plasma Xanthine Oxidase Activity Is Predictive of Cardiovascular Disease in Patients with Chronic Kidney Disease, Independently of Uric Acid Levels.
    Gondouin B, Jourde-Chiche N, Sallee M, Dou L, Cerini C, Loundou A, Morange S, Berland Y, Burtey S, Brunet P, Guieu R, Dussol B.
    Nephron; 2015; 131(3):167-74. PubMed ID: 26426087
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Cardiovascular events and death in Japanese patients with chronic kidney disease.
    Tanaka K, Watanabe T, Takeuchi A, Ohashi Y, Nitta K, Akizawa T, Matsuo S, Imai E, Makino H, Hishida A, CKD-JAC Investigators.
    Kidney Int; 2017 Jan; 91(1):227-234. PubMed ID: 27884399
    [Abstract] [Full Text] [Related]

  • 26. Serum Calcification Propensity and Clinical Events in CKD.
    Bundy JD, Cai X, Mehta RC, Scialla JJ, de Boer IH, Hsu CY, Go AS, Dobre MA, Chen J, Rao PS, Leonard MB, Lash JP, Block GA, Townsend RR, Feldman HI, Smith ER, Pasch A, Isakova T, CRIC Study Investigators.
    Clin J Am Soc Nephrol; 2019 Nov 07; 14(11):1562-1571. PubMed ID: 31658949
    [Abstract] [Full Text] [Related]

  • 27. Plasma endocan levels associate with inflammation, vascular abnormalities, cardiovascular events, and survival in chronic kidney disease.
    Yilmaz MI, Siriopol D, Saglam M, Kurt YG, Unal HU, Eyileten T, Gok M, Cetinkaya H, Oguz Y, Sari S, Vural A, Mititiuc I, Covic A, Kanbay M.
    Kidney Int; 2014 Dec 07; 86(6):1213-20. PubMed ID: 24988065
    [Abstract] [Full Text] [Related]

  • 28. Associations among chronic kidney disease, high total p-cresylsulfate and major adverse cardiac events.
    Wang CP, Lu LF, Yu TH, Hung WC, Chiu CA, Chung FM, Hsu CC, Lu YC, Lee YJ, Houng JY.
    J Nephrol; 2013 Dec 07; 26(1):111-8. PubMed ID: 22460182
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Association of serum sodium levels with all-cause and cardiovascular mortality in chronic kidney disease: Results from a prospective observational study.
    Chiu DY, Kalra PA, Sinha S, Green D.
    Nephrology (Carlton); 2016 Jun 07; 21(6):476-82. PubMed ID: 26426983
    [Abstract] [Full Text] [Related]

  • 33. Association of serum chloride level with mortality and cardiovascular events in chronic kidney disease: the CKD-ROUTE study.
    Mandai S, Kanda E, Iimori S, Naito S, Noda Y, Kikuchi H, Akazawa M, Oi K, Toda T, Sohara E, Okado T, Sasaki S, Rai T, Uchida S.
    Clin Exp Nephrol; 2017 Feb 07; 21(1):104-111. PubMed ID: 27039905
    [Abstract] [Full Text] [Related]

  • 34. The significance of micro- and macrovascular biomarkers on cardiovascular outcome in chronic kidney disease: a prospective cohort study.
    Cseprekál O, Egresits J, Tabák Á, Nemcsik J, Járai Z, Babos L, Fodor E, Farkas K, Godina G, Kárpáthi KI, Kerkovits L, Marton A, Nemcsik-Bencze Z, Németh Z, Sallai L, Kiss I, Tislér A.
    J Hum Hypertens; 2016 Jul 07; 30(7):449-55. PubMed ID: 26424101
    [Abstract] [Full Text] [Related]

  • 35. Intraindividual interleukin-6 variations on the cardiovascular prognosis of patients with chronic renal disease.
    Goicoechea M, Quiroga B, García de Vinuesa S, Verdalles U, Reque J, Panizo N, Arroyo D, Santos A, Macías N, Luño J.
    Ren Fail; 2012 Jul 07; 34(8):1002-9. PubMed ID: 22746155
    [Abstract] [Full Text] [Related]

  • 36. Selecting a prognostic renal surrogate for patients with hepatocellular carcinoma undergoing transarterial chemoembolization.
    Lee YH, Hsu CY, Huang YH, Su CW, Lin HC, Lee RC, Chiou YY, Huo TI, Lee SD.
    J Gastroenterol Hepatol; 2012 Oct 07; 27(10):1581-8. PubMed ID: 22497632
    [Abstract] [Full Text] [Related]

  • 37. Association Between Circulating Ketone Bodies and Worse Outcomes in Hemodialysis Patients.
    Obokata M, Negishi K, Sunaga H, Ishida H, Ito K, Ogawa T, Iso T, Ando Y, Kurabayashi M.
    J Am Heart Assoc; 2017 Oct 03; 6(10):. PubMed ID: 28974498
    [Abstract] [Full Text] [Related]

  • 38. Circulating MicroRNA-125b Predicts the Presence and Progression of Uremic Vascular Calcification.
    Chao CT, Liu YP, Su SF, Yeh HY, Chen HY, Lee PJ, Chen WJ, Lee YM, Huang JW, Chiang CK, Hung KY, Chen HW.
    Arterioscler Thromb Vasc Biol; 2017 Jul 03; 37(7):1402-1414. PubMed ID: 28522697
    [Abstract] [Full Text] [Related]

  • 39. FGF-23 and Osteoprotegerin but not Fetuin-A are associated with death and enhance risk prediction in non-dialysis chronic kidney disease stages 3-5.
    Alderson HV, Ritchie JP, Middleton R, Larsson A, Larsson TE, Kalra PA.
    Nephrology (Carlton); 2016 Jul 03; 21(7):566-73. PubMed ID: 27334353
    [Abstract] [Full Text] [Related]

  • 40. Beta2-microglobulin is a better predictor of treatment-free survival in patients with chronic lymphocytic leukaemia if adjusted according to glomerular filtration rate.
    Delgado J, Pratt G, Phillips N, Briones J, Fegan C, Nomdedeu J, Pepper C, Aventin A, Ayats R, Brunet S, Martino R, Valcarcel D, Milligan D, Sierra J.
    Br J Haematol; 2009 Jun 03; 145(6):801-5. PubMed ID: 19388937
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.